# Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand

> **NCT04764422** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mahidol University** · enrollment: 455 (actual)

## Conditions studied

- Covid-19
- SARS Pneumonia
- Pneumonia, Viral
- Covid-19 Vaccine

## Interventions

- **BIOLOGICAL:** Normal Saline
- **BIOLOGICAL:** NDV-HXP-S vaccine

## Key facts

- **NCT ID:** NCT04764422
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-20
- **Primary completion:** 2022-09-12
- **Final completion:** 2022-09-12
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2022-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764422, "Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04764422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*